151 related articles for article (PubMed ID: 26950381)
1. Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients.
Mazza P; Palazzo G; Minoia C; Amurri B; Pisapia G
Bone Marrow Transplant; 2016 Jul; 51(7):1002-3. PubMed ID: 26950381
[No Abstract] [Full Text] [Related]
2. Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.
Zenz T; Döhner H; Bunjes D
Bone Marrow Transplant; 2003 Aug; 32(4):437-8. PubMed ID: 12900782
[TBL] [Abstract][Full Text] [Related]
3. Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report.
Tenenbaum T; Hasan C; Kramm CM; Janssen G; Laws HJ; Wessalowski R; Bode U; Göbel U
Onkologie; 2004 Apr; 27(2):131-7. PubMed ID: 15138344
[TBL] [Abstract][Full Text] [Related]
4. Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support.
Wandt H; Schaefer-Eckart K; Wilhelm M
Haematologica; 2005 Sep; 90(9):1292-4. PubMed ID: 16154863
[TBL] [Abstract][Full Text] [Related]
5. The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products.
Ciurea S; Beri R; Dobogai L; Chunduri S; Mahmud N; Rondelli D; Peace D
Bone Marrow Transplant; 2006 Feb; 37(3):325-7. PubMed ID: 16314850
[No Abstract] [Full Text] [Related]
6. Management of Jehovah's Witness patients with haematological problems.
Nash MJ; Cohen H
Blood Rev; 2004 Sep; 18(3):211-7. PubMed ID: 15183904
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support.
Al-Nawakil C; Quarre MC; Heshmati F; Deau B; Park S; Dreyfus F; Bouscary D; Tamburini J
Br J Haematol; 2013 Jun; 161(5):738-740. PubMed ID: 23480574
[No Abstract] [Full Text] [Related]
8. Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients.
Beck A; Lin R; Reza Rejali A; Rubens M; Paquette R; Vescio R; Merin N; Guerrero M; Federizo Y; Lua M; Uy L; Hernandez L; Allred M; Legaspi R; Leaverton M; Oliva S; Castillo R; Dean L; Bourke J; Cooper S; Gharapetian S; Causin J; Lopiccolo C; Ann Snoussi L; VanStrien P; Lill M; Linhares YP
Bone Marrow Transplant; 2020 Jun; 55(6):1059-1067. PubMed ID: 31898692
[TBL] [Abstract][Full Text] [Related]
9. Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience.
Mazza P; Prudenzano A; Amurri B; Palazzo G; Pisapia G; Stani L; Pricolo G
Bone Marrow Transplant; 2003 Aug; 32(4):433-6. PubMed ID: 12900781
[TBL] [Abstract][Full Text] [Related]
10. Jehovah's Witnesses and cardiac surgery: a single institution's experience.
McCartney S; Guinn N; Roberson R; Broomer B; White W; Hill S
Transfusion; 2014 Oct; 54(10 Pt 2):2745-52. PubMed ID: 24809815
[TBL] [Abstract][Full Text] [Related]
11. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
Ford PA; Grant SJ; Mick R; Keck G
J Clin Oncol; 2015 May; 33(15):1674-9. PubMed ID: 25870085
[TBL] [Abstract][Full Text] [Related]
12. SCT in Jehovah's Witnesses: the bloodless transplant.
Sloan JM; Ballen K
Bone Marrow Transplant; 2008 May; 41(10):837-44. PubMed ID: 18246110
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in Jehovah's Witnesses patients in a center of northeastern Brazil.
Garcia JH; Coelho GR; Feitosa Neto BA; Nogueira EA; Teixeira CC; Mesquita DF
Arq Gastroenterol; 2013 Apr; 50(2):138-40. PubMed ID: 23903624
[TBL] [Abstract][Full Text] [Related]
14. Kidney and pancreas transplants in Jehovah's witnesses: ethical and practical implications.
Boggi U; Vistoli F; Del Chiaro M; Croce C; Signori S; Marchetti P; Del Prato S; Rizzo G; Mosca F
Transplant Proc; 2004 Apr; 36(3):601-2. PubMed ID: 15110606
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation in Jehovah's witnesses.
Detry O; Roover AD; Delwaide J; Kaba A; Joris J; Damas P; Lamy M; Honoré P; Meurisse M
Transpl Int; 2005 Aug; 18(8):929-36. PubMed ID: 16008742
[TBL] [Abstract][Full Text] [Related]
16. A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem Cell Transplant.
Zhao JC; Arnall JR; Martin AL; Atrash S; Bhutani M; Voorhees P; Avalos B; Copelan E; Ghosh N; Hamadani M; Usmani S; Ford P
Biol Blood Marrow Transplant; 2019 Oct; 25(10):e305-e309. PubMed ID: 31295572
[TBL] [Abstract][Full Text] [Related]
17. Haematological care of the Jehovah's Witness patient.
Marsh JC; Bevan DH
Br J Haematol; 2002 Oct; 119(1):25-37. PubMed ID: 12358900
[No Abstract] [Full Text] [Related]
18. [Experience in kidney transplantation without blood transfusion: kidney transplantation transfusion-free in Jehovah's Witnesses. First communication in Mexico].
Hernández-Navarrete LS; Hernández-Jiménez JD; Jiménez-López LA; Budar-Fernández LF; Méndez-López MT; Martínez-Mier G
Cir Cir; 2013; 81(5):450-3. PubMed ID: 25125065
[TBL] [Abstract][Full Text] [Related]
19. Jehovah's witnesses, blood transfusions and transplantations.
Sarteschi LM
Transplant Proc; 2004 Apr; 36(3):499-501. PubMed ID: 15110571
[TBL] [Abstract][Full Text] [Related]
20. Mid-term clinical outcomes in cardiac surgery of Jehovah's witnesses.
Pompei E; Tursi V; Guzzi G; Vendramin I; Ius F; Muzzi R; Auci E; Badano LP; Livi U
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):170-4. PubMed ID: 19934767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
